• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expression of androgen receptor is negatively regulated by p53.雄激素受体的表达受p53负调控。
Neoplasia. 2007 Dec;9(12):1152-9. doi: 10.1593/neo.07769.
2
Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.LNCaP前列腺癌细胞的雄激素非依赖性生长由功能获得性突变型p53介导。
Cancer Res. 2003 May 1;63(9):2228-33.
3
Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.Twist1/AR信号通路介导的上皮-间质转化与前列腺癌去势抵抗之间的串扰
Endocr Relat Cancer. 2015 Dec;22(6):889-900. doi: 10.1530/ERC-15-0225. Epub 2015 Aug 26.
4
Identification of novel androgen receptor target genes in prostate cancer.前列腺癌中新型雄激素受体靶基因的鉴定
Mol Cancer. 2007 Jun 6;6:39. doi: 10.1186/1476-4598-6-39.
5
Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha.核因子-κB与B-myb在肿瘤坏死因子α对雄激素受体表达的负调控中的相互作用
Mol Endocrinol. 2008 Feb;22(2):273-86. doi: 10.1210/me.2007-0332. Epub 2007 Nov 1.
6
Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.雄激素受体作为 ZEB2 表达的调节剂及其在前列腺癌上皮间质转化中的意义。
Endocr Relat Cancer. 2014 May 8;21(3):473-86. doi: 10.1530/ERC-13-0514. Print 2014 Jun.
7
Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.雄激素非依赖性前列腺癌细胞中雄激素受体cDNA表达的雄激素上调。
Steroids. 1996 Sep;61(9):531-9. doi: 10.1016/s0039-128x(96)00086-4.
8
Androgen receptor overexpression in prostate cancer linked to Pur alpha loss from a novel repressor complex.前列腺癌中雄激素受体过表达与新型抑制复合物中Purα缺失有关。
Cancer Res. 2008 Apr 15;68(8):2678-88. doi: 10.1158/0008-5472.CAN-07-6017.
9
Myosin VI is a modulator of androgen-dependent gene expression.肌球蛋白VI是雄激素依赖性基因表达的调节因子。
Oncol Rep. 2009 Nov;22(5):991-5. doi: 10.3892/or_00000526.
10
The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression.miR-96 和 RARγ 信号轴调控雄激素信号和前列腺癌进展。
Oncogene. 2019 Jan;38(3):421-444. doi: 10.1038/s41388-018-0450-6. Epub 2018 Aug 17.

引用本文的文献

1
Investigating Intensity and Percentage of p53 Nuclear Expression in Prostate Cancer: Findings from a Cohort of U.S. Military Veterans.研究前列腺癌中p53核表达的强度和百分比:来自美国退伍军人队列的研究结果。
Cancers (Basel). 2025 Mar 17;17(6):1004. doi: 10.3390/cancers17061004.
2
Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies.p53调控与功能中的性别差异:个性化癌症治疗的新见解
Cells. 2025 Feb 28;14(5):363. doi: 10.3390/cells14050363.
3
METTL3-mediated mA modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy.METTL3 介导的 circGLIS3 的 mA 修饰促进前列腺癌进展,代表了 ARSI 治疗的一个潜在靶点。
Cell Mol Biol Lett. 2024 Aug 14;29(1):109. doi: 10.1186/s11658-024-00628-z.
4
Hair Thickness Growth Effect of Adenosine Complex in Male-/Female-Patterned Hair Loss via Inhibition of Androgen Receptor Signaling.腺苷复合物通过抑制雄激素受体信号通路对男性/女性型脱发的毛发生长作用。
Int J Mol Sci. 2024 Jun 13;25(12):6534. doi: 10.3390/ijms25126534.
5
AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.由NF-κB和p38丝裂原活化蛋白激酶信号介导的前列腺癌基质中的雄激素受体缺失会破坏基质形态发生素的产生。
Oncogene. 2024 Jun;43(27):2092-2103. doi: 10.1038/s41388-024-03064-7. Epub 2024 May 20.
6
Acne Transcriptomics: Fundamentals of Acne Pathogenesis and Isotretinoin Treatment.痤疮转录组学:痤疮发病机制和异维 A 酸治疗的基础。
Cells. 2023 Nov 10;12(22):2600. doi: 10.3390/cells12222600.
7
Increased Local Testosterone Levels Alter Human Fallopian Tube mRNA Profile and Signaling.局部睾酮水平升高会改变人输卵管的mRNA图谱和信号传导。
Cancers (Basel). 2023 Mar 30;15(7):2062. doi: 10.3390/cancers15072062.
8
Ribonuclease H2 Subunit A Preserves Genomic Integrity and Promotes Prostate Cancer Progression.核糖核酸酶 H2 亚基 A 可维持基因组完整性并促进前列腺癌进展。
Cancer Res Commun. 2022 Aug 25;2(8):870-883. doi: 10.1158/2767-9764.CRC-22-0126. eCollection 2022 Aug.
9
hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen-induced transcriptional response in prostate cancer.hSSB1(NABP2/OBFC2B)调节前列腺癌细胞中的 DNA 损伤和雄激素诱导的转录反应。
Prostate. 2023 May;83(7):628-640. doi: 10.1002/pros.24496. Epub 2023 Feb 22.
10
Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.透明质酸-FGF2 衍生肽生物缀合物,可同时抑制 FGFR2 和 AR,作为痤疮拮抗剂。
J Nanobiotechnology. 2023 Feb 17;21(1):55. doi: 10.1186/s12951-023-01812-7.

本文引用的文献

1
Expression and function of the human androgen-responsive gene ADI1 in prostate cancer.人类雄激素反应基因ADI1在前列腺癌中的表达及功能
Neoplasia. 2007 Aug;9(8):643-51. doi: 10.1593/neo.07415.
2
Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch1: implications for cancer cell fate determination after genotoxic stress.在人类癌细胞系中恢复p53表达可上调Notch1的表达:对基因毒性应激后癌细胞命运决定的影响。
Neoplasia. 2007 May;9(5):427-34. doi: 10.1593/neo.07211.
3
Analysis of the MDM2 antagonist nutlin-3 in human prostate cancer cells.人前列腺癌细胞中MDM2拮抗剂Nutlin-3的分析
Prostate. 2007 Jun 1;67(8):900-6. doi: 10.1002/pros.20568.
4
Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.雌激素化合物对雄激素非依赖性前列腺癌的抑制作用与免疫相关基因表达增加有关。
Neoplasia. 2006 Oct;8(10):862-78. doi: 10.1593/neo.06328.
5
Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.阴阳平衡:泛素化介导的p53和c-Myc调控
Neoplasia. 2006 Aug;8(8):630-44. doi: 10.1593/neo.06334.
6
Identification of cell cycle regulatory genes as principal targets of p53-mediated transcriptional repression.鉴定细胞周期调控基因作为p53介导的转录抑制的主要靶点。
J Biol Chem. 2006 Sep 1;281(35):25134-42. doi: 10.1074/jbc.M513901200. Epub 2006 Jun 23.
7
Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival.雄激素受体突变(T877A)促进前列腺癌细胞生长和细胞存活。
Oncogene. 2006 Jun 29;25(28):3905-13. doi: 10.1038/sj.onc.1209424. Epub 2006 Apr 24.
8
DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation.DU-145和PC-3人前列腺癌细胞系表达雄激素受体:对雄激素受体功能和调控的意义。
FEBS Lett. 2006 Apr 17;580(9):2294-300. doi: 10.1016/j.febslet.2006.03.041. Epub 2006 Mar 24.
9
Transcriptional regulation by p53: one protein, many possibilities.p53介导的转录调控:一种蛋白,多种可能。
Cell Death Differ. 2006 Jun;13(6):951-61. doi: 10.1038/sj.cdd.4401916.
10
Defining aggressive prostate cancer using a 12-gene model.使用12基因模型定义侵袭性前列腺癌。
Neoplasia. 2006 Jan;8(1):59-68. doi: 10.1593/neo.05664.

雄激素受体的表达受p53负调控。

Expression of androgen receptor is negatively regulated by p53.

作者信息

Alimirah Fatouma, Panchanathan Ravichandran, Chen Jianming, Zhang Xiang, Ho Shuk-Mei, Choubey Divaker

机构信息

Edward Hines Jr. VA Hospital, Hines, IL 60141, USA.

出版信息

Neoplasia. 2007 Dec;9(12):1152-9. doi: 10.1593/neo.07769.

DOI:10.1593/neo.07769
PMID:18084622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2134911/
Abstract

Increased expression of androgen receptor (AR) in prostate cancer (PC) is associated with transition to androgen independence. Because the progression of PC to advanced stages is often associated with the loss of p53 function, we tested whether the p53 could regulate the expression of AR gene. Here we report that p53 negatively regulates the expression of AR in prostate epithelial cells (PrECs). We found that in LNCaP human prostate cancer cells that express the wild-type p53 and AR and in human normal PrECs, the activation of p53 by genotoxic stress or by inhibition of p53 nuclear export downregulated the expression of AR. Furthermore, forced expression of p53 in LNCaP cells decreased the expression of AR. Conversely, knockdown of p53 expression in LNCaP cells increased the AR expression. Consistent with the negative regulation of AR expression by p53, the p53-null HCT116 cells expressed higher levels of AR compared with the isogenic HCT116 cells that express the wildtype p53. Moreover, we noted that in etoposide treated LNCaP cells p53 bound to the promoter region of the AR gene, which contains a potential p53 DNA-binding consensus sequence, in chromatin immunoprecipitation assays. Together, our observations provide support for the idea that the loss of p53 function in prostate cancer cells contributes to increased expression of AR.

摘要

前列腺癌(PC)中雄激素受体(AR)表达增加与向雄激素非依赖状态转变相关。由于PC进展至晚期常与p53功能丧失有关,我们检测了p53是否能调节AR基因的表达。在此我们报告p53在前列腺上皮细胞(PrECs)中负向调节AR的表达。我们发现在表达野生型p53和AR的LNCaP人前列腺癌细胞以及人正常PrECs中,基因毒性应激或抑制p53核输出激活p53后会下调AR的表达。此外,在LNCaP细胞中强制表达p53会降低AR的表达。相反,在LNCaP细胞中敲低p53表达会增加AR的表达。与p53对AR表达的负向调节一致,与表达野生型p53的同基因HCT116细胞相比,p53基因缺失的HCT116细胞表达更高水平的AR。此外,我们注意到在依托泊苷处理的LNCaP细胞中,在染色质免疫沉淀试验中p53与AR基因的启动子区域结合,该区域含有一个潜在的p53 DNA结合共有序列。总之,我们的观察结果支持了前列腺癌细胞中p53功能丧失导致AR表达增加这一观点。